Elanco Animal Health Incorporatedis an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
The company traces its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage with the new plant and animal sciences research being combined into Lilly's Agro-Industrial division led by George Barnes. In the 1960s, the Agro-Industrial division was reorganised launching Elanco Products, short for the parent company name, Eli Lilly and Company.
In the 1980s research moved away from plant sciences and focused on animal health and food quality. In the 1990s another reorganisation led to the company being renamed Elanco Animal Health, focusing solely on animal health.[
In 2007 the business acquired Ivy Animal Health and launched its companion animal business. In 2008 Elanco partnered with Heifer International.
In 2010 the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site. In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health. In 2012 the business acquired ChemGen Corp. In 2014, the business acquired Lohmann SE and Lohmann Animal Health and Novartis Animal Health. In 2016 Elanco expanded its US-based business, acquiring vaccines from Boehringer Ingelheim Vetmedica.
In 2019, year, the US FDA approved rabacfosadine, a first-in-class treatment for canine lymphoma. The business continued to expand is US-business, acquiring Aratana Therapeutics,[11] and its first-in-class treatment for canine osteoarthritis. İn 2020 year the business acquired Bayer's animal health business.
Diusapet Company based in Italy and produces dry food for dogs and cats with the brands Alleva Holistic, Alleva Natural, Alleva Equilibrium, Alleva Care, NeoBreeder and pet care products - Neo Lupus.
Our expertise dates back on 1901, year of creation of the very first natural product line for pet care and pet health in veterinary French market. Nowadays, we represent a multinational team of experts in clinical pet nutrition, pet food producers and professional breeders of cats and dogs, joined by the passion and love for animals. We base the development of our products on scientific evidences, we perform studies on our foods in a completely ethic and cruelty-free way, using our highest-quality, completely natural pet foods and pet care products on animals living in family conditions or that are naturally affected by disease. In this way, we cure them for free and at the same time we prove the efficacy of our products. All our efforts, in the last 120 years, are aimed to ensure the wellbeing and longevity of Your pet
Diusapet is leader in Italy, Europe and Middle East in the Pet Food sector and it produces dry food for dogs and cats with the brands Alleva Holistic, Alleva Natural, Alleva Equilibrium, Alleva Care and pet care products - Neo Lupus.
LOXAVET pharma GmbH was founded in 2012 as a business development company for veterinary pharmaceuticals, located in Germany (Unterschleißheim, close to Munich).
The founder, E. Raab, developed Caniquantel® Plus for dogs and cats and Caniquantel® Plus XL for dogs in 1995 and 2000, and since then has been interested in gaining access to numerous markets around the world.
It has established itself in the antiparasitic markets of at least 15 EU countries, Russia, Kazakhstan, Azerbaijan, Georgia and the UAE. In 2024, LOXAVET's latest antiparasitic product will be launched in Germany and will be launched in parts of the European Union and non-EU countries through MRP.
Therefore, LOXAVET pharma GmbH, as a pharmaceutical company, has extensive experience in the veterinary field. LOXAVET pharman GmbH has its own manufacturing facility in Germany and is responsible for production, regulatory work, secondary packaging and batch release.
LOXAVET pharma GmbH is the holder of registrations in most European countries. LOXAVET pharma GmbH has a manufacturing license and GMP certificate.
LOXAVET pharma GmbH has a permanent distribution partner in all countries and carries out secondary packaging individually according to all registrations.